Depressant fluvoxamine not effective in reducing COVID inflammation--study

Primary tabs

posted by mike kraft on Tue, 2023-09-19 19:43
Study shows no benefits of antidepressant for COVID-19 symptoms - UPI.com Researchers studied fluvoxamine because previous evidence suggested that it might be able to reduce inflammation caused by the virus. UPI

 

A clinical trial designed to test repurposed medications for their impact on fighting COVID-19 has found no benefit to taking the antidepressant fluvoxamine (Luvox) to ease coronavirus symptoms.

Country / Region Tags: 
Global
United States
General Topic Tags: 
COVID-19
Treatments
Disease
Research
Problem, Solution, SitRep, or ?: 
Analysis
Groups this Group Post belongs to: 
- Private group -
howdy folks

User login

What is the weather on the sun

Language

English Arabic Danish Dutch Filipino Finnish French German Greek Haitian Creole Hebrew Hindi Indonesian Irish Italian Japanese Korean Persian Portuguese Russian Spanish Swedish Thai Turkish Ukrainian Vietnamese

Anonymous's groups in this site

User is not a member of any group.

Your groups across all your sites

User is not a member of any group.

Who's online

There are currently 0 users online.

Facebook  Twitter  RSS